Learn how to manage an IgA nephropathy flare with this detailed action plan. Understand symptoms and prevention to safeguard ...

Medically reviewed by Femi Aremu, PharmD IgA nephropathy (IgAN) is a progressive kidney disease. Progression rate depends on ...

ABSTRACT: Background: Massive generalized lymphadenopathy (MGL) as an initial manifestation of systemic lupus erythematosus (SLE) is rare. The Case: A previously healthy 18-year-old man presented with ...

Please provide your email address to receive an email when new articles are posted on . Pegcetacoplan reduced proteinuria in patients with rare complement-mediated glomerular diseases vs. placebo.

I've evaluated outdoor and fitness equipment for over five years. It's gotten easier to find protein-infused processed food items to try to meet your daily nutrient goals. We asked the experts if you ...

Sherri Gordon, CLC is a certified professional life coach, author, and journalist covering health and wellness, social issues, parenting, and mental health. She also has a certificate of completion ...

If you're looking to build muscle, hitting the gym might be your first move. But how does protein intake factor into your bulking plan? The Recommended Dietary Allowance (RDA) for protein is 0.36 ...

Everyone seems to be talking about protein right now—and for good reason. “Protein is the building block of every tissue in our body, from muscles and bones to organs, skin, and hair,” says Rachel ...

Snack bars, yogurts, ice cream, even bottled water: it seems like food makers have worked out ways to slip extra protein into just about anything as they seek to capitalize on a growing consumer trend ...

Gemcitabine is a widely used chemotherapeutic agent for pancreatic adenocarcinoma, that is associated with rare but serious renal complications including thrombotic microangiopathy (TMA). We report a ...

A investigator reported that sibeprenlimab halved baseline proteinuria levels over 12 months in trial patients with IgA nephropathy. Sibeprenlimab continues to reduce proteinuria in patients with IgA ...

Treatment with telitacicept for 39 weeks resulted in a rapid, clinically meaningful, and statistically significant reduction in proteinuria, with a favorable safety profile Telitacicept demonstrated a ...